Sinopharm Group Co. Ltd.
Simbolis: 1099.HK
HKSE
20.5
HKDRinkos kaina šiandien
4.2750
P/E santykis
0.0000
PEG koeficientas
63.93B
MRK kapitalizacija
- 0.05%
DIV pajamingumas
Sinopharm Group Co. Ltd. (1099-HK) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 63809.1 | 55222.1 | 43541.2 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0.5 | 0.5 | 11.7 | ||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 185790.4 | 201909.9 | 172575.5 | ||||||||||||||||||
balance-sheet.row.inventory | 0 | 60027.6 | 60925.8 | 51499.6 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 1159.8 | 1348.5 | 20506 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 336835.1 | 319406.4 | 290922.1 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 18049.7 | 17792.4 | 17597.5 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 7185.7 | 7155.6 | 7199 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 4858.4 | 4870.1 | 5003 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 12044.1 | 12025.7 | 12202 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 10550.7 | 9840 | 9172.5 | ||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 1963.7 | 1979.7 | 1787.1 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 3951.6 | 3731 | 3731.1 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 46559.7 | 45368.8 | 44490.2 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 0 | 383394.8 | 364775.1 | 335412.3 | ||||||||||||||||||
balance-sheet.row.account-payables | 0 | 154747.4 | 144616.7 | 132866.9 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 56527 | 54633.2 | 56699.7 | ||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 2988.7 | 3278.7 | 3008.1 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 17254.9 | 14957 | 11668.5 | ||||||||||||||||||
Deferred Revenue Non Current | 0 | 369.2 | 413 | 376.2 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 7495.6 | 35713.1 | 8119.6 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 21585.5 | 19743 | 16451.8 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 5217.4 | 4842.5 | 4797.9 | ||||||||||||||||||
balance-sheet.row.total-liab | 0 | 263076.1 | 254705.9 | 235758.4 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 1787.2 | 4390.6 | 4388.1 | ||||||||||||||||||
balance-sheet.row.common-stock | 0 | 3120.7 | 3120.7 | 3120.7 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 49410.1 | 42870.1 | 38515.8 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -4373.3 | -4390.6 | -4388.1 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 24637.6 | 22077.8 | 20249.6 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 74582.2 | 68068.6 | 61886 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 383394.8 | 364775.1 | 335412.3 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 45736.5 | 42000.6 | 37767.9 | ||||||||||||||||||
balance-sheet.row.total-equity | 0 | 120318.7 | 110069.2 | 99653.9 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||
Total Investments | 0 | 10550.7 | 9840.5 | 9184.3 | ||||||||||||||||||
balance-sheet.row.total-debt | 0 | 73781.9 | 69590.2 | 68368.2 | ||||||||||||||||||
balance-sheet.row.net-debt | 0 | 9973.3 | 14368.6 | 24838.8 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 18563.8 | 17003.2 | 15598.1 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 4165 | 3922.1 | 3597.1 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | -2547.1 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | -18.6 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2073.7 | -12101.3 | -8720 | |||||||||||||||||
cash-flows.row.account-receivables | 0 | 710.1 | -26717.2 | -22631.4 | |||||||||||||||||
cash-flows.row.inventory | 0 | -9504.2 | -4345.3 | -3675.4 | |||||||||||||||||
cash-flows.row.account-payables | 0 | -710.1 | 26717.2 | 22631.4 | |||||||||||||||||
cash-flows.row.other-working-capital | 0 | 7430.5 | -7756 | -5044.6 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 308.6 | 484.2 | 3245 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -2417.5 | -2255.6 | -2087.3 | |||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -336.7 | -488.4 | -2427.4 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -100 | -75 | -40 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 211.5 | 298.6 | 23.7 | |||||||||||||||||
cash-flows.row.other-investing-activites | 0 | -946.9 | 1253.4 | 2328.3 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -3589.6 | -1267 | -2202.8 | |||||||||||||||||
cash-flows.row.debt-repayment | 0 | -101705.3 | -104707.1 | -96838.2 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 3600.4 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 96841.4 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2340.5 | -2153.3 | -1865.1 | |||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 98352.3 | 92167.4 | 287.4 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -5693.5 | -14693 | 2025.9 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 11.5 | 3 | 8.6 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 11692.2 | -6648.8 | 10986.3 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 55221.6 | 43529.4 | 50178.3 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 43529.4 | 50178.3 | 39192 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 20963.8 | 9308.1 | 11154.6 | |||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -2417.5 | -2255.6 | -2087.3 | |||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 18546.3 | 7052.4 | 9067.3 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 596569.6 | 552147.6 | 521051.2 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 548057.9 | 504713.5 | 477000.6 | ||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 48511.7 | 47434.1 | 44050.6 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -41.8 | -676.2 | -589.2 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 26234.7 | 24227 | 22609.3 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 574292.6 | 528940.4 | 499610 | ||||||||||||||||||
income-statement-row.row.interest-income | 0 | 743.4 | 542.8 | 558.6 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 2956.6 | 3520.3 | 3756.8 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -2806.3 | -2040.6 | -2708.8 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -41.8 | -676.2 | -589.2 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -2806.3 | -2040.6 | -2708.8 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 2956.6 | 3520.3 | 3756.8 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 4430.2 | 8204.8 | 7153.1 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 0 | 20209.2 | 20604.5 | 19712 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 19512.1 | 18563.8 | 17003.2 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 4502.3 | 4218.4 | 3938.4 | ||||||||||||||||||
income-statement-row.row.net-income | 0 | 9053.8 | 14345.4 | 13064.8 |
Dažnai užduodami klausimai
Kas yra Sinopharm Group Co. Ltd. (1099.HK) bendras turtas?
Sinopharm Group Co. Ltd. (1099.HK) bendras turtas yra 383394844000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.084.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 22.484.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.015.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.038.
Kas yra Sinopharm Group Co. Ltd. (1099.HK) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 9053760000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 73781852000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 26234719000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.